Home
>
ipos-financial-filings
| Revenue | -- |
|---|---|
| Net Income | -$1,078,357.00 |
| Total Assets | $36,907.00 |
| Total Liabilities | $$1,083,393.00 |
| Stockholders' Equity | ($1,046,486.00) |
| COMPANY NAME | FORM TYPE | DATE RECEIVED | VIEW |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. | S-1 | 2024-09-25 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2024-11-08 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2024-12-09 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2024-12-20 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2025-01-10 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2025-01-29 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2025-02-06 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1 | 2024-09-25 00:00:00 | Link |
| Apimeds Pharmaceuticals US, Inc. | S-1/A | 2025-02-10 00:00:00 | Link |
